Is Tirzepatide Easier on the Eyes Than GLP-1s?

Using tirzepatide is linked to lower risks of developing primary open-angle glaucoma and elevated eye pressure in patients with type 2 diabetes than using GLP-1 receptor agonists, a study finds.
Medscape Medical News